<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35332308</PMID><DateCompleted><Year>2022</Year><Month>04</Month><Day>21</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1759-5010</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>5</Issue><PubDate><Year>2022</Year><Month>May</Month></PubDate></JournalIssue><Title>Nature reviews. Cardiology</Title><ISOAbbreviation>Nat Rev Cardiol</ISOAbbreviation></Journal><ArticleTitle>Long COVID and cardiovascular disease: a learning health system approach.</ArticleTitle><Pagination><StartPage>287</StartPage><EndPage>288</EndPage><MedlinePgn>287-288</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41569-022-00697-7</ELocationID><Abstract><AbstractText>Cardiovascular disease is both a risk factor and potential outcome of the direct, indirect and long-term effects of COVID-19. A recent analysis in &gt;150,000 survivors of COVID-19 demonstrates an increased 1-year risk of numerous cardiovascular diseases. Preventing and managing this new disease burden presents challenges to health systems and requires a learning health system approach.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mohamed</LastName><ForeName>Mohamed O</ForeName><Initials>MO</Initials><AffiliationInfo><Affiliation>Institute of Health Informatics, University College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Banerjee</LastName><ForeName>Amitava</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institute of Health Informatics, University College London, London, UK. ami.banerjee@ucl.ac.uk.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016420">Comment</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nat Rev Cardiol</MedlineTA><NlmUniqueID>101500075</NlmUniqueID><ISSNLinking>1759-5002</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentOn"><RefSource>Nat Med. 2022 Mar;28(3):583-590. doi: 10.1038/s41591-022-01689-3</RefSource><PMID Version="1">35132265</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002318" MajorTopicYN="Y">Cardiovascular Diseases</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000077321" MajorTopicYN="Y">Deep Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000080891" MajorTopicYN="Y">Learning Health System</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>A.B. has received research funding from AstraZeneca and is a trustee of Long Covid SOS and the South Asian Health Foundation. M.O.M. declares no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>3</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>3</Month><Day>25</Day><Hour>5</Hour><Minute>37</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>3</Month><Day>24</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35332308</ArticleId><ArticleId IdType="pmc">PMC8943785</ArticleId><ArticleId IdType="doi">10.1038/s41569-022-00697-7</ArticleId><ArticleId IdType="pii">10.1038/s41569-022-00697-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Banerjee A, et al. Estimating excess 1-year mortality associated with the COVID-19 pandemic according to underlying conditions and age: a population-based cohort study. Lancet. 2020;395:1715&#x2013;1725. doi: 10.1016/S0140-6736(20)30854-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30854-0</ArticleId><ArticleId IdType="pmc">PMC7217641</ArticleId><ArticleId IdType="pubmed">32405103</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohamed MO, et al. Impact of COVID-19 on cardiac procedure activity in England and associated 30-day mortality. Eur. Heart J. Qual. Care Clin. Outcomes. 2021;7:247&#x2013;256. doi: 10.1093/ehjqcco/qcaa079.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ehjqcco/qcaa079</ArticleId><ArticleId IdType="pmc">PMC7665465</ArticleId><ArticleId IdType="pubmed">33079204</ArticleId></ArticleIdList></Reference><Reference><Citation>Groff D, et al. Short-term and long-term rates of postacute sequelae of SARS-CoV-2 infection: a systematic review. JAMA Netw. Open. 2021;4:e2128568. doi: 10.1001/jamanetworkopen.2021.28568.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.28568</ArticleId><ArticleId IdType="pmc">PMC8515212</ArticleId><ArticleId IdType="pubmed">34643720</ArticleId></ArticleIdList></Reference><Reference><Citation>Office for National Statistics. Prevalence of ongoing symptoms following coronavirus (COVID-19) infection in the UK, https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/prevalenceofongoingsymptomsfollowingcoronaviruscovid19infectionintheuk/3march2022 (March 2022).</Citation></Reference><Reference><Citation>Xie Y, Xu E, Bowe B, Al-Aly Z. Long-term cardiovascular outcomes of COVID-19. Nat. Med. 2022 doi: 10.1038/s41591-022-01689-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01689-3</ArticleId><ArticleId IdType="pmc">PMC8938267</ArticleId><ArticleId IdType="pubmed">35132265</ArticleId></ArticleIdList></Reference><Reference><Citation>Raman B, Bluemke DA, L&#xfc;scher TF, Neubauer S. Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus. Eur. Heart J. 2022;43:1157&#x2013;1172. doi: 10.1093/eurheartj/ehac031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehac031</ArticleId><ArticleId IdType="pmc">PMC8903393</ArticleId><ArticleId IdType="pubmed">35176758</ArticleId></ArticleIdList></Reference><Reference><Citation>Ikonomidis, I. et al. Myocardial work and vascular dysfunction are partially improved at 12 months after COVID-19 infection. Eur. J. Heart Fail., 10.1002/ejhf.2451 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9087421</ArticleId><ArticleId IdType="pubmed">35138689</ArticleId></ArticleIdList></Reference><Reference><Citation>Heightman M, et al. Post-COVID-19 assessment in a specialist clinical service: a 12-month, single-centre, prospective study in 1325 individuals. BMJ Open Respir. Res. 2021;8:e001041. doi: 10.1136/bmjresp-2021-001041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjresp-2021-001041</ArticleId><ArticleId IdType="pmc">PMC8587466</ArticleId><ArticleId IdType="pubmed">34764200</ArticleId></ArticleIdList></Reference><Reference><Citation>Tran J, et al. Patterns and temporal trends of comorbidity among adult patients with incident cardiovascular disease in the UK between 2000 and 2014: A population-based cohort study. PLoS Med. 2018;15:e1002513. doi: 10.1371/journal.pmed.1002513.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1002513</ArticleId><ArticleId IdType="pmc">PMC5839540</ArticleId><ArticleId IdType="pubmed">29509757</ArticleId></ArticleIdList></Reference><Reference><Citation>Clift AK, et al. Living risk prediction algorithm (QCOVID) for risk of hospital admission and mortality from coronavirus 19 in adults: national derivation and validation cohort study. Br. Med. J. 2020;371:m3731. doi: 10.1136/bmj.m3731.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3731</ArticleId><ArticleId IdType="pmc">PMC7574532</ArticleId><ArticleId IdType="pubmed">33082154</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>